Roopa Ramamoorthi, PhD
Director Catalyst Invent
Innovation Ventures
Chancellor/EVC/FAS
Roopa Ramamoorthi brings a diverse scientific background in drug development, bacteriology, biotechnology, and engineering.
Show full bio (160 words) Hide full bio
Prior to joining UCSF, Roopa was Associate Director Partnering and Scientific Affairs at BIO Ventures for Global Health, where her focus was putting together collaborations between academic, non profit and pharmaceutical organizations to accelerate the development of drugs, vaccines and diagnostics for Neglected Tropical Diseases, TB and Malaria for the WIPO Re:Search Consortium. She worked for Bayer in California for more than five years as a scientist and senior scientist in development of antibody and other biological therapeutics and evaluating and bringing in platform technologies and has experience in science and technology consulting with Strategic Perspectives. Roopa received her Ph.D. in biochemical engineering from the California Institute of Technology (Caltech) and conducted postdoctoral research at the University of Washington and at MIT. She is a registered patent agent and holds a Project Management Professional (PMP) certification. Roopa grew up in India where she received her B.S. in chemical engineering from the Indian Institute of Technology in Mumbai.
Publications (10)
Top publication keywords:
SchistosomaCooperative BehaviorProtein Kinase InhibitorsCoenzymesAntimalarialsQuinolonesGram-Negative Aerobic BacteriaPovertyNeglected DiseasesDrug DesignDioxygenasesAnthelminticsAntitubercular AgentsSchistosomiasisDrug Repositioning
-
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues.
International journal for parasitology. Drugs and drug resistance 2022 Cortopassi WA, Gunderson E, Annunciato Y, Silva AES, Dos Santos Ferreira A, Garcia Teles CB, Pimentel AS, Ramamoorthi R, Gazarini ML, Meneghetti MR, Guido RVC, Pereira DB, Jacobson MP, Krettli AU, … -
Repurposing pharma assets: an accelerated mechanism for strengthening the schistosomiasis drug development pipeline.
Future medicinal chemistry 2015 Ramamoorthi R, Graef KM, Dent J -
WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships.
International journal for parasitology. Drugs and drug resistance 2014 Ramamoorthi R, Graef KM, Dent J -
WIPO re:search: catalyzing collaborations to accelerate product development for diseases of poverty.
Chemical reviews 2014 Ramamoorthi R, Graef KM, Krattiger A, Dent JC -
WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases.
Pharmaceutical patent analyst 2013 Dent J, Ramamoorthi R, Graef K, Nelson LM, Wichard JC
Show all (5 more) Hide
-
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.
Hepatology (Baltimore, Md.) 2004 Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, Krebs B, Kraft S, Zahn S, Brocks B, Feirt N, Mei B, Cho MS, Ramamoorthi R, Roldan G, Ng P, Lum P, Hirth-Dietrich C, Tomkinson A, Brenner … -
Sequence of the Corynebacterium glutamicum pyruvate carboxylase gene.
Applied microbiology and biotechnology 1998 Koffas MA, Ramamoorthi R, Pine WA, Sinskey AJ, Stephanopoulos G -
Characterization and nucleotide sequence of pqqE and pqqF in Methylobacterium extorquens AM1.
Journal of bacteriology 1996 Springer AL, Ramamoorthi R, Lidstrom ME -
Transcriptional analysis of pqqD and study of the regulation of pyrroloquinoline quinone biosynthesis in Methylobacterium extorquens AM1.
Journal of bacteriology 1995 Ramamoorthi R, Lidstrom ME -
Isolation, phenotypic characterization, and complementation analysis of mutants of Methylobacterium extorquens AM1 unable to synthesize pyrroloquinoline quinone and sequences of pqqD, pqqG, and pqqC.
Journal of bacteriology 1994 Morris CJ, Biville F, Turlin E, Lee E, Ellermann K, Fan WH, Ramamoorthi R, Springer AL, Lidstrom ME